Sotera Health Q3 net rev $285M (+8.5% YoY); net income $17M vs loss $14M; reaffirms FY outlook

Sotera Health Co

2024-Q3 EPS reported $0.11 revenue$810,238,000

Q3 net revenues $285M, up 8.5% YoY (8.9% constant currency); net income $17M ($0.06 diluted) vs net loss $14M in Q3 2023.
Adjusted EBITDA $146M, +9.0% YoY; Adjusted EPS $0.17, +$0.01 YoY.
Nine-month 2024 net revenues $810M (+9.6% YoY); net income $32M ($0.11 diluted) vs $13M prior year.
Reaffirming 2024 net revenue and Adjusted EBITDA outlook ranges.
CEO cites Nordion cobalt-60 timing benefit; investor day planned for Nov 20, 2024 in NYC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.